Celesio to become number one also in specialty pharma distribution in Brazil
- Majority shareholding of 60 per cent in Oncoprod Group, a specialty pharmaceutical distributor with a focus on highly complex medicines, e.g. against cancer
- Building up a leading position in the growth market Brazil
Celesio, one of the leading international service providers in the pharmaceutical and healthcare markets, has today announced the acquisition of 60 per cent of the Brazilian Oncoprod Group, São Paulo. Oncoprod is the leading wholesaler for specialty pharmaceuticals in Brazil.
"The Brazilian pharma market offers many opportunities for growth," says Markus Pinger, Chairman of the Management Board and CEO of Celesio.
"Brazil's healthcare market grows above average. Particularly the area of Specialty Pharmaceuticals is highly attractive. The acquisition of Oncoprod is therefore an optimal addition to Panpharma, our Brazilian wholesaler. With both companies we are focusing on our core competencies in pharmaceutical wholesale and distribution of specialty pharmaceuticals."
Wolfgang Mähr, the Celesio Management Board member responsible for the Pharmacy Solutions division, adds: "Precisely in the specialty pharmaceuticals segment, experts expect double-digit growth rates in the coming years. We want to participate in this with Oncoprod."
In Brazil, specialty pharmaceuticals - predominantly pharmaceuticals for complex diseases such as cancer - are available virtually exclusively in hospitals and special clinics, but not in pharmacies. Distribution is not via normal pharmaceutical wholesale, but via specialised distribution companies such as Oncoprod because, as a rule, these medicines must be stored and distributed according to special requirements in terms of handling, service and cooling. The Panpharma and Oncoprod business complement each other with respect to customers and product ranges without overlap.
Oncoprod was founded in 1995 in São Paulo. The company has grown strongly in recent years and today has more than 300 employees. In the current year, estimated revenue is expected to exceed 800 million Brazilian reais (around 350 million euro). The company's main customers are private special clinics, private and state-run hospitals, patients as well as government institutions. Oncoprod is the only distributor focused solely on specialty pharmaceuticals, operating with seven branches throughout Brazil.
McKesson Europe AG
Celesio is one of the leading international service providers within the pharmaceutical and healthcare markets. We are active in 27 countries worldwide and employ around 47,000 employees in our three divisions Patient and Consumer Solutions, Pharmacy Solutions and Manufacturer Solutions. Approximately 2,300 of Celesio's own retail pharmacies, as part of Patient and Consumer Solutions, serve around half a million customers every day. In our wholesale activities, the core business of Pharmacy Solutions, more than 130 wholesale branches deliver to approximately 65,000 pharmacies - day in, day out. In the Manufacturer Solutions division, we offer pharmaceutical manufacturers logistics, marketing and sales solutions and operate in the area of Efficient Care Pharma.